CT-guided Lung Biopsy Risk Optimization Method

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Mar 25, 2024

Keywords

ClinConnect Summary

This clinical trial, called the CT-guided Lung Biopsy Risk Optimization Method, is looking at ways to make lung biopsies safer. Specifically, researchers want to see if injecting a small amount of fluid into the chest area during the biopsy can help lower the risk of a condition called pneumothorax, which is when air leaks into the space around the lungs and can cause breathing problems. They will also explore how positioning patients during the biopsy can help.

To participate in this study, individuals must be at least 18 years old and able to understand the study's details. They should have a lung lesion that is uncertain or suspicious and cannot be sampled using a different method. However, people who have bleeding in the chest area, more than one lesion needing a biopsy, or are pregnant cannot participate. This study is not yet recruiting participants, but once it begins, those who qualify can expect careful monitoring and support throughout the biopsy process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ability to provide informed consent (knowledge of project languages), \>18 years.
• • Indeterminate or suspicious lung lesion unsuitable for transbronchial biopsy or Status after unsuccessful transbronchial biopsy
• • Indication for biopsy given by referring specialist (in patients).
• Exclusion Criteria:
• • Preintervention bleeding into the pleural cavity
• • More than 1 lesion should be biopsied at the same time
• • Infiltration of the thoracic wall
• • Pregnancy